Genomica expands commercial operations to Scandinavia
Genomica SAU (Zeltia) has achieved another step in its internationalisation process by establishing, as of 17th January 2013, its Scandinavian (Denmark, Sweden and Norway) subsidiary, Genomica AB.
Based in Lund, Sweden, Genomica AB intends to support the Scandinavian market, due to its strategic importance and also for its high growth potential. Genomica began its international expansion in 2006, focusing initially on the European market. In 2007, the company expanded its market to countries in Central and South America. Currently, Genomica is present in more than 35 countries worldwide and is actively continuing its global expansion.